Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination

Women's Oncology Review

Volumn 4, Issue 4, 2004, Pages 315-316

  Warner, E ^b   Plewes, D ^b   Hill, K ^b   Narod, S ^b   Prance, Sarah ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CALCIFICATION; BREAST CANCER; BREAST DUCT; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL EXAMINATION; FAMILIAL CANCER; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; INTERMETHOD COMPARISON; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE; ULTRASOUND;

EID: 17144411535     PISSN: 14733404     EISSN: None     Source Type: Journal    
DOI: 10.1080/14733400500035016     Document Type: Article

References (5)

1. Stoutjeskijk MJ, Boetes C, Jager GJ, et al. Magnetic Resonance Imaging and Mammography in Women with a Hereditary Risk of Breast Cancer. J Natl Cancer Inst 2001;93:1095-102
2. Leach MO, Eeles RA, Turnbull LW, et al. The UK National Study of Magnetic Resonance Imaging for Screening for Breast Cancer (MARIBS). J Exp Clin Cancer Res 2002;21:107-114
3. Kriege M, Brekelmans CTM, Boetes C, et al. Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition. NEJM 2004;351:427-37
4. Scheuer L, Kauff N, Robson M, et al. Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers. J Clin Oncol 2002;20:1260-8
5. Robson M, Offit K. Breast MRI for Women with Hereditary Cancer Risk. JAMA 2004;292:1368-70